Brief: Synthaverse Signs Annex To Deal With Biodrug To Expand Onko BCG 100 Distribution To Australia And New Zealand

Synthaverse SA

13/07/2026 11:53

July 13 (Reuters) - Synthaverse SA SVEP.WA:
SIGNS ANNEX TO DEAL WITH BIODRUG TO EXPAND ONKO BCG 100 DISTRIBUTION TO AUSTRALIA AND NEW ZEALAND
TOTAL VALUE OF ORDERS FOR PRODUCT CONCERNING AUSTRALIA AND NEW ZEALAND DURING FIRST FIVE YEARS FOLLOWING REGISTRATION IN INDICATED MARKETS SET AT EUR 4.5 MILLION
BIODRUG TO BE RESPONSIBLE FOR REGISTRATION PROCESS AND REGULATORY COSTS IN AUSTRALIA AND NEW ZEALAND
Source text: https://shorturl.at/kxOTc
Further company coverage: SVEP.WA

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))